-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster II

Symposia: T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Christiane Querfeld, MD, PhD1, Julia J Scarisbrick, MD, FRCP, MBBS2*, Oleg Akilov, MD, PhD3*, Payal Arora, PhD4*, Yi Liu, PhD4*, Martine Bagot, MD, PhD5*, Raul Cordoba, MD, PhD6, Richard Cowan, MD7*, Alejandro Martín García-Sancho8*, Larisa J Geskin, MD9*, Auris O Huen, MD, PharmD10*, Jatin Jadwani, BDS, MSc, PhD11*, Steven Morris, MD, MRCP, FRCR12*, Pablo L Ortiz-Romero, MD, PhD13*, Akshaya Patel, PhD4*, Lauren C. Pinter-Brown, MD, FACP14*, Ramon M Pujol, MD, PhD15*, Pietro Quaglino, MD16*, Nakhle S Saba, MD17, Ragini Vuppugalla, PhD4*, Henry Zhao, PhD4* and Youn H. Kim, MD18

1Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
2University Hospital Birmingham, Birmingham, United Kingdom
3University of Pittsburgh, Pittsburgh, PA
4Kyowa Kirin, Inc., Princeton, NJ
5Hôpital Saint Louis, APHP, Inserm U976, Université Paris Cité, Paris, France
6Hematology Department, Health Research Institute IIS-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
7Christie Hospital Foundation NHS Trust, University of Manchester, Manchester, United Kingdom
8Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain
9Department of Dermatology, Columbia University Irving Medical Center, New York, NY
10Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
11Kyowa Kirin, GmbH, Dusseldorf, Germany
12Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom
13Department of Dermatology, Hospital 12 de Octubre Medical School, Complutense University of Madrid, Madrid, Spain
14University of California Irvine, Irvine, CA
15Dermatology Department, Hospital del Mar, Barcelona, Spain
16Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy
17LSUHSC, Our Lady of the Lake Cancer Institute, New Orleans, LA
18Stanford University, Stanford, CA

Juying Wei1*, Wenjuan Yu2*, Zhengming Jin, M.D.3*, Keshu Zhou4*, Haiyan Yang, PhD5, Fei Li6, Lanfang Li7*, Bo Zhang8*, Miao Hu, MD, phd9, Yanping Zhang9*, Xinglu Zhou9* and Jie Jin, M.D.10

1Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Zhejiang Provincial Clinical Research Center For Hematological disorders, Hangzhou, China
3Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
4Department of Hematology, Henan Cancer Hospital, Zhengzhou, China
5Department of Lymphoma, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
6Department of Hematology, Jiangxi Clinical Research Center for Hematologic Disease, Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China;, Nanchang, China
7Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
8Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China
9HealZen Therapeutics Co., Ltd, Hangzhou, China
10Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Yuma Nato, MD1,2*, Kana Miyazaki, MD, PhD2, Ayumi Fujimoto, MD3, Senzo Taguchi, MD, PhD4*, Naoko Asano, MD, PhD5, Jun Amaki, MD, PhD6*, Wataru Munakata, MD, PhD7*, Yuko Shirouchi8*, Nobuko Kubota, MD, PhD9,10*, Takeshi Maeda, MD, PhD11*, Jun Takizawa, MD, PhD12*, Kimikazu Yakushijin, MD, PhD13, Rika Sakai, MD, PhD14*, Hideyuki Nakazawa, MD, PhD15*, Masahiro Takeuchi, MD, PhD16, Noriko Fukuhara, MD, PhD17, Yuri Miyazawa, MD, PhD18*, Ryoji Tokiya, MD, PhD19*, Tohru Murayama, MD, PhD20*, Isao Tawara, MD, PhD2, Yasuo Ejima, MD, PhD21*, Ritsuro Suzuki, MD, PhD3 and Motoko Yamaguchi, MD, PhD1

1Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan
2Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
3Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Japan
4Department of Radiation Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
5Nagano Prefectural Suzaka Hospital, Suzaka, JPN
6Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
7Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
8Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
9Division of Hematology, Saitama Cancer Center, Saitama, Japan
10Department of Hematology, Shin-Yurigaoka General Hospital, Kawasaki, Japan
11Department of Hematology and Oncology, Kurashiki Central Hospital, Kurashiki, Japan
12Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan
13Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan
14Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan
15Department of Hematology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan
16Division of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan
17Department of Hematology, Tohoku University School of Medicine, Sendai, Japan
18Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan
19Department of Radiology, Kawasaki Medical School, Kurashiki, Japan
20Department of Hematology, Hyogo Cancer Center, Akashi, Japan
21Department of Radiology, Dokkyo Medical University, Shimotsuga, Japan

Daisuke Nakamura, MD, PhD1,2*, Satsuki Owatari, MD, PhD3*, Takayoshi Miyazono, MD, PhD4*, Hidetoshi Nakashima, MD5*, Akihiko Arai, MD, PhD6*, Hirosaka Inoue, MD7*, Kentaro Yonekura, MD, PhD8*, Kazuyuku Fujii, MD, PhD9*, Shogo Takeuchi, MD10*, Satoshi Fukutoku, MD1,5*, Seiichiro Nakabeppu, MD11*, Kodai Shima, MD1,12*, Naosuke Arima, MD1,13*, Yuhei Kamada, MD, PhD1,3*, Koichi Haraguchi, MD, PhD3*, Hideaki Kawada, MD, PhD6*, Yoshikiyo Ito, MD, PhD4*, Maki Otsuka, MD, PhD3*, Shuichi Hanada, MD, PhD14, Makoto Yoshimitsu, MD, PhD15 and Kenji Ishitsuka, MD, PhD16

1Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan
2Department of Hematology, Saiseikai Sendai Hospital, Kagoshima, Japan
3Department of Hematology, Kagoshima Medical Center, Kagoshima, Japan
4Department of Hematology, Imamura General Hospital, Kagoshima, Japan
5Department of Hematology, Seijinkai Ikeda Hospital, Kagoshima, Japan
6Department of Hematology and Rheumatology, Kagoshima City Hospital, Kagoshima, Japan
7Department of Hematology, Imakire General Hospital, Kagoshima, Japan
8Department of Dermatology, Imamura General Hospital, Kagoshima, Japan
9Department of Dermatology, Kagoshima University Hospital, Kagoshima, Japan
10Department of Hematology, Izuro Imamura Hospital, Kagoshima, Japan
11Department of Hematology, Izumi General Medical Center, Kagoshima, Japan
12Department of Hematology, Kirishima Medical Center, Kagoshima, Japan
13Department of Hematology, Izumi Regional Medical Center, Kagoshima, Japan
14Department of General Internal Medicine, Ibusuki Medical Center, Kagoshima, Japan
15Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University Hospital, Kagoshima, Japan
16Kagoshima University Hospital, Kagoshima, Japan

Sara Niyazi, DO1, Xiaoqing Yu, PhD2*, Carly Harro, PhD3*, Lewis Glass, MD4*, Lubomir Sokol, MD, PhD5, Jose Conejo-Garcia, MD, PhD6*, Ling Zhang, MD7 and Yumeng Zhang, MD5

1Department of Pathology and Cell Biology, University of South Florida, TAMPA, FL
2Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA
4Department of Dermatology, University of South Florida, Tampa, FL
5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Department of Immunology, Duke University, Durham, NC
7Department of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer and Research Institute, Tampa, FL

Neha Mehta-Shah, MD1, Pier Luigi Zinzani, MD, PhD2, Eric D. Jacobsen, MD3, Jasmine Zain, MD4, Monica Mead, MD5, Carla Casulo, MD6, Giuseppe Gritti, MD, PhD7*, Lauren C. Pinter-Brown, MD, FACP8*, Koji Izutsu, MD, PhD9, Ohad S Bentur, MD10, David Sidransky, MD11*, Jonathan E. Brammer12, Barbara Pro, MD13, Christopher P. Fox, MBChB(Hons), PhD, FRCP14,15 and Steven Horwitz, MD16

1Washington University School of Medicine in St. Louis, St Louis, MO
2Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
3Dana Farber Cancer Institute, Boston, MA
4City of Hope, Duarte, CA
5Department of Medicine/Division of Hematology and Oncology, UCLA Medical Center, Los Angeles, CA
6University of Rochester Medical Center, Rochester, NY
7Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy
8University of California Irvine, Irvine, CA
9National Cancer Center Hospital, Tokyo, Japan
10Secura Bio, Inc., Las Vegas, NV
11Johns Hopkins University, Baltimore, MD
12Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
13Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
14Department of Haematology, Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
15School of Medicine, University of Nottingham, Nottingham, United Kingdom
16Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Xi Chen1*, Li Xie2*, Ming Jiang2* and Liqun Zou2*

1Department of Radiotherapy, Cancer Center, West China Hospital of Sichuan University, Chengdu, China
2Department of Head & Neck Oncology, Cancer Center, West China Hospital of Sichuan University, Chengdu, China

Ramsay Hafer, BS1*, Teresa Duong, BS1*, Jenna Mandel, BS1*, Henry Y Yang, BS1*, Julianna Tolotta, BS1*, Lauren Banner, MD1*, Safiyyah Bhatti, MD2*, Pierluigi Porcu3 and Neda Nikbakht, MD, PhD1

1Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
2Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
3Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA

Natalia Pin Chuen Zing, MD1,2*, Thais Fischer, MD3*, Eliana Miranda, PhD, MEd4*, Maria Almeida Dias, MD5*, Yung Gonzaga, MD6*, Renata Lyrio R Baptista, MD7*, Guilherme D Amarante, MD8*, Rony Schaffel, MD, PhD9, Frederico Lisboa Nogueira, MD10, Davimar Bortucchi, MD, PhD11*, Rodrigo Santucci12*, Sergio Brasil, MD13*, Karin Z Cecyn, MD14*, Vera Figueiredo, MD15*, Nelson S Castro, MD16*, Yana S Rabelo, MD17*, Gilnara Fontinele Silva, MD, MSc18*, Abrahão Elias Hallack Neto, MD, PhD19*, Patricia Giacon, MD20*, Milene Matedi, MD21*, Diego Vila Cle22*, Juliana Pereira, MD, PhD23, Fernando Barroso, MD24*, Renata R Souza, MD25*, Henry Quintero, MD26*, Denisse Castro, MD27, Brady E Beltran, MD28*, Daniel J Enriquez, MD29*, Jule F Vasquez, MD30, Claudia Roche, MD31*, Daniel Artiles, MD32*, Fabiola Valvert, MD33*, Luis Mario Villela, MD34*, Ana Carolina Oliver, MD35, Laura Korin, MD36*, Macarena Roa, MD37*, Camila Peña, MD38, Maria Alejandra Torres Viera, MD39*, Seisha Alana von Glasenapp, Medical Doctor40, Alfredo Quiroz, MD41*, Cesar Samanez-Figari, MD42*, Rosa Oliday Rios Jimenez43*, Sally Paredes, MD27*, Eduardo Edelman Saul, MD44, Casey Bermack, MD45, Kelly Meza, MD46*, Bryan Valcarcel, MD, MPH47, Carmino De Souza, MD, PhD4*, Luis Malpica, MD48* and Carlos Chiattone, MD, PhD13,49

1Prevent Senior, SAO PAULO, Brazil
2Hospital Beneficencia Portuguesa de SP, Sao Paulo, Brazil
3AC Camargo Cancer Center, Sao Paulo, AC, Brazil
4Centro de Hematologia e Hemoterapia (HEMOCENTRO), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
5Federal da Bahia Hospital, Salvador, Brazil
6Cancer National Institute, Rio De Janeiro, Brazil
7State University of Rio de Janeiro, Rio De Janeiro, Brazil
8Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
9HUCFF / UFRJ, Rio de Janeiro, Brazil
10Luxemburgo Hospital, Belo Horizonte, Brazil
11ABC Medical School, Santo Andre, Brazil
12Hemocentro Sao Lucas, Sao Paulo, BRA
13Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
14Federal University of Sao Paulo, Sao Paulo, Brazil
15Servidor Publico Estadual de Sao Paulo, Sao Paulo, Brazil
16Hospital de Cancer de Barretos, Barretos, São Paulo, BRA
17Goias Federal University, Goias, Brazil
18Aldenora Bello Hospital, Sao Luis, Brazil
19Juiz de Fora Federal University, Juiz de Fora, Brazil
20Santa Marcelina Hospital, Sao Paulo, Brazil
21Santa Casa de Belo Horizonte, Belo Horizonte, Brazil
22USP Ribeirão, Ribeirao Preto, Brazil
23University of São Paulo, Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, São Paulo, São Paulo, Brazil
24TERAPIA CELULAR, HOSPITAL MONTE KLINIKUM, FORTALEZA, Brazil
25Federal University of Ceara, Fortaleza, Brazil
26Universidad del Valle, Cali, Colombia
27Hospital Edgardo Rebagliati Martins, Lima, Peru
28Servicio Oncología Médica, Hospital Edgardo Rebagliati, Lima, Peru
29Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru
30Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
31Hospital Armando Milan Castro, Vila Clara, Cuba
32Hospital Arnoldo Milan Castro, Vila Clara, Cuba
33INCAN, Mexico, Mexico
34Mexico, Mexico City, Mexico
35Hospital Britanico de Montevideo, Montevideo, Uruguay
36CABA- Alexander Fleming Institute, Olivos, Argentina
37Santiago Hospital del Salvador, Santiago, Chile
38Hospital Del Salvador, Santiago, Chile
39Clinica Santa Sofia, Caracas, Venezuela (Bolivarian Republic of)
40Hospital Central Instituto de Previsión Social, Asuncion, Paraguay
41Departamento de Hematología, Hospital Central Instituto de Previsión Social, Asunción, Paraguay
42Oncosalud, AUNA, Lima, Peru
43Hospital Clínico Quirúrgico Hermanos Amejeiras, La Habana, Cuba
44Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
45University of Texas MD Anderson Cancer Center, Houston, TX
46Baylor College of Medicine, Houston, TX
47George Washington University, Washington, DC
48Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
49Santa Casa de São Paulo. São Paulo – Brazil, São Paulo, Brazil

Hayder Saeed, MD1, Melanie Mediavilla Varela, pH.D2*, Eva Sahakian, PhD3*, Mahrukh Naqvi1*, Qiangxing Mo, PhD1*, Ling Zhang, MD4, Rikesh Makanji, MD1*, Yumeng Zhang, MD5, Ning Dong, MD MS6, Leidy L. Isenalumhe, MD, MS7, Sameh Gaballa, MD1, Julio C. Chavez, MD8, Bijal D Shah, MD1, Celeste M. Bello, MD7, Lubomir Sokol, MD, PhD5 and Javier Pinilla-Ibarz, MD, PhD1

1Moffitt Cancer Center, Tampa, FL
2Immunology/Immune-Oncology, Moffitt Cancer Center, Tampa, FL
3Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer and Research Institute, Tampa, FL
5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6H Lee Moffitt Cancer Center and Research Institute, Tampa
7H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Lutz, FL

Gao Yan1, Xue-Ping Li2*, Bing Bai, M.D, PhD3*, Xiaoxiao Wang1*, Xuanye Zhang, M.D, PhD3* and Huiqiang Huang, M.D, PhD3

1Sun Yat-Sen University Cancer Center, Guangzhou, China
2Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
3Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

Nechama Dreyfus, MD1*, Emma Cordover2*, Kith Pradhan, PhD3*, Latoya S Townsend, DNP4*, Mendel Goldfinger5*, Ioannis Mantzaris, MD5, Nishi Shah, MBBS, MPH5, Aditi Shastri, MD6, Noah Kornblum, MD5, Dennis L Cooper, MD5, Ridhi Gupta, MD5, Lauren Shapiro, MD5, Kira Gritsman, MD, PhD5, Marina Konopleva7, Beth McLellan, MD8*, Simon Zhen, MD9*, Alyssa de Castro, PharmD10*, Salvatore Lia, PharmD11*, Virleny Garcia, PharmD4*, Roy Browne, PharmD4*, Eric Meyerowitz, MD4*, Yoram Puius, MD4*, Margaret McCort, MD12*, Yang Shi, MD13*, Yanhua Wang, MD14*, Amit Verma, MD15, B. Hilda Ye, PhD16, Murali Janakiram, MBBS17, Abdul-Hamid Bazarbachi, MD18* and R. Alejandro Sica, MD19

1Department of Oncology, Montefiore Medical Center, Flushing, NY
2Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
3Montefiore Einstein Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
4Montefiore Medical Center, Bronx
5Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
6Hematology/Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
7Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
8Albert Einstein Collge of Medicine, Bronx, NY
9Albert Einstein College of Medicine, Bronx, NY
10Montefiore Medical Center, Bronx, NY
11Department of Pharmacy, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
12Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY
13Department of Pathology, Montefiore Medical Center, Bronx, NY
14Department of Pathology, Montefiore Medical Center, Bronx
15Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY
16Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
17Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
18Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY
19Department of Oncology, Montefiore Medical Center, Bronx, NY

Alison Moskowitz, MD1, Ranjana H. Advani, MD2, Nivetha Ganesan, MPH3*, Tiffany Chang, MS3*, Helen Hancock, ANP3*, Theresa Davey, MMSc, PA-C3*, Tayler Miller4*, Angela Gibaldi, RN3*, Marcel Smith, NP3*, Alicia Assini, NP3*, Lisa Sarmasti, NP3*, Paige Collins3*, Suviasini Patel3*, Andrew K.N Le5*, Catherine Maccaro4*, Ellie Casper, MS, DPT1*, Natasha Galasso3*, Sarima Subzwari3*, Marwah Jihad6*, Paola Ghione, MD, MSEpi3, Richard T. Hoppe, MD7, Brandon S. Imber, MD, MA8, William T. Johnson, DO9, Colette Owens, MD1, Santosha A. Vardhana, MD, PhD1,10, Heiko Schoder, MD3*, Joachim Yahalom, MD8 and Steven Horwitz, MD1

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Stanford Cancer Institute, Stanford University, Stanford, CA
3Memorial Sloan Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering Cancer Center, NY
5Stanford Cancer Institute, Palo Alto
6Memorial Sloan Kettering Cancer Center, NEW YORK, NY
7Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
8Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
9Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
10Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York

Christina Poh, MD1,2, Xueyan Chen, MD, PhD2,3*, Jenna M. Voutsinas, MPH2*, Edus H. Warren, MD, PhD1,2, Mazyar Shadman, MD, MPH1,2, Ryan C. Lynch, MD2,4, Brian G. Till, MD1,2, Chaitra S. Ujjani, MD1,2, Mengyang Di, MD, PhD1,2, Vikram Raghunathan, MD1,2*, Stephen D. Smith, MD1,2, Qian Vicky Wu, PhD2*, Sindhu Cherian, MD2,3* and Ajay K. Gopal, MD1,2

1Division of Hematology and Oncology, University of Washington, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Division of Pathology, University of Washington, Seattle, WA
4University of Washington, Seattle, WA

Philipp Berning1*, Maud Ngoya2*, Hervé Finel2*, Nassila Thani2*, Evgenii Shumilov1*, Depei Wu, MD, PhD3, Haiwen Huang, M.D., PhD3*, Won Seog Kim4*, Anne Cairoli, MD5*, Alessandra Tucci, MD6, Guillaume Dachy7*, Romain Gounot8*, Anne Wilke9*, Marek Werth9*, Christof Scheid10*, Peter Dreger11, Jose Luis Lopez Lorenzo, MD12*, Adrian Bloor, Phd FRCP FRCPath13*, Joanna Romejko-Jarosinska14*, Alain Gadisseur, MD, PhD15*, Roland Schroers, MD16*, Péter Pál Reményi, MD17*, Anne Sirvent18*, Monica Poiani19*, Khalid Halahleh, MD20*, Jacques-Emmanuel Galimard, PhD2*, Georg Lenz1, Bertram Glass, MD21*, Ana Maria Sureda Balari, MD, PhD22, Ali Bazarbachi, MD, PhD23 and Norbert Schmitz, MD1*

1Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
2European Society for Blood and Marrow Transplantation, Paris, France
3National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
4Samsung Medical Center, Center for Hematologic Malignancy, Seoul, Korea, Republic of (South)
5Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
6Hematology, ASST Spedali Civili, Brescia, Italy
7Cliniques Universitaires St. Luc, Brussels, Belgium
8Lymphoid Malignancies Unit, HôPital Universitaire Henri Mondor, Assistanc, CréTeil, FRA
9University Hospital Frankfurt, Goethe University, Frankfurt Main, Germany
10Cologne University Hospital, Cologne, Germany
11Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
12Fundacion Jimenez Diaz, Madrid, ESP
13The Christie NHS Foundation Trust, Manchester, United Kingdom
14Maria Sklodowska-Curie Institute - Oncology Centre, Warsaw, Poland
15Antwerp University Hospital, Edegem, Belgium
16Department of Hematology and Oncology, Ruhr Univeristy Bochum, Bochum, Germany
17Department of Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary
18CHU Lapeyronie, Montpellier, France
19Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy
20King Hussein Cancer Centre Adult BMT Program, Amman, Jordan
21Department of Hematology and Stem Cell Transplantation, Helios Klinikum Berlin-Buch, Berlin, Germany
22Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
23American University of Beirut Dept. of Medicine, Beirut, Lebanon

Gao Yan1, Xue-Ping Li2*, Xiaoxiao Wang1*, Xiaoyu Hong3*, Bing Bai, M.D, PhD4*, Xuanye Zhang, M.D, PhD4*, Jialing Zhuang5* and Huiqiang Huang, M.D, PhD4

1Sun Yat-Sen University Cancer Center, Guangzhou, China
2Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
3Nanjing Geneseeq Technology Inc, Guangzhou, China
4Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
5Sun Yat-sen University Cancer Center (China), Guangzhou, China

Suying Lu1*, Junting Huang2*, Ruiqing Cai1*, Yan Gao3*, Jia Zhu1*, Juan Wang4*, Yi Que1*, Zi-Jun Zhen5*, Feifei Sun1*, Huiqiang Huang6 and Yizhuo Zhang5*

1Sun Yat-Sen University Cancer Center, Guangzhou, China
2Sun Yat-Sen University Cancer Center, GUang, China
3Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, NY, China
4Sun Yat-sen University Cancer Center, Guangzhou, CHN
5Sun Yat-Sen University Cancer Center, Guangzhou, CHN
6State Key Laboratory of Oncology in South China, Department of Medical Oncology, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

Lijie Zeng1*, Lei Yang2*, Mei Li1* and Liang Wang3*

1Beijing Tongren Hospital, Beijing, China
2Beijing Tongren Hospital, Capital Medical University,Department of Hematology, Beijing, China
3Beijing Tongren Hospital, Guangzhou, China

Anup Kumar Trikannad, MD, Sruthi Vellanki, MD*, Jim Zhongning Chen, MD, Alan Baltz, MD*, Mamatha Gaddam, MD, Ankur Varma, MD, Muthu V. Kumaran, MD* and Cesar Giancarlo Gentille Sanchez, MD

University of Arkansas for Medical Sciences, Little Rock, AR

Kate Cwynarski, MBBS, PhD, FRCP, FRCPath1*, Eva Domingo Domenech, MD2*, David Sidransky, MD3*, Ohad S Bentur, MD4 and Pier Luigi Zinzani, MD, PhD5

1University College London Hospitals NHS Foundation Trust, London, United Kingdom
2Catalan Institute of Oncology, Hospital Duran i Reynals. IDIBELL, Barcelona, Spain
3Johns Hopkins University, Baltimore, MD
4Secura Bio, Inc., Las Vegas, NV
5Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy

*signifies non-member of ASH